ScottThomasRottinghausMD

PubMed

• 33 citations
  Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two...
  Régis Peffault de Latour, Robert A. Brodsky, Stephan Ortiz, Antonio M. Risitano, Jun H. Jang, Peter Hillmen, A. D. Kulagin, Austin G. Kulasekararaj, Scott T. Rottingha...> ;British Journal of Haematology. 2020 Nov 1
• 5 citations
  Assessing Preferences for Rare Disease Treatment: Qualitative Development of the Paroxysmal Nocturnal Hemoglobinuria Patient Preference Questionnaire (PNH-PPQ©).
  Karen Kaiser, Susan Yount, Christa E. Martens, Kimberly Webster, Sara Shaunfield, Amy Sparling, John Devin Peipert, David Cella, Scott T. Rottinghaus, Bonnie M.K. Dona...> ;Patient Preference and Adherence. 2020 Apr 5
• 208 citations
  Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study
  Jong Wook Lee, Flore Sicre de Fontbrune, Lily Wong Lee Lee, Viviani Pessoa, Sandra Fátima Menosi Gualandro, Wolfgang Füreder, Vadim Ptushkin, Scott T. Rottinghaus, Lor...> ;Blood. 2019 Feb 7
• 203 citations
  Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study.
  Austin G. Kulasekararaj, Anita J. Hill, Scott T. Rottinghaus, Saskia Langemeijer, Richard A. Wells, F. Ataulfo Gonzalez-Fernandez, Anna Gaya, Jong Wook Lee, Emilio Oje...> ;Blood. 2019 Feb 7
• 59 citations
  Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria: results of 2 phase 1b/2 studies.
  Alexander Röth, Scott T. Rottinghaus, Anita J. Hill, Eric Bachman, Jin Seok Kim, Hubert Schrezenmeier, Louis Terriou, Alvaro Urbano-Ispizua, Richard A. Wells, Jun Ho J...> ;Blood Advances. 2018 Sep 11
• 13 citations
  Pharmacokinetic Characteristics of Tofacitinib in Adult Patients With Moderate to Severe Chronic Plaque Psoriasis
  Guangli Ma, Rujia Xie, Bruce Strober, Richard G. Langley, Kaori Ito, Sriram Krishnaswami, Robert Wolk, Hernan Valdez, Scott T. Rottinghaus, Anna M. Tallman, Pankaj Gupta> ;Clinical Pharmacology in Drug Development. 2018 Aug 1
• 25 citations
  T-cell-mediated immune response to pneumococcal conjugate vaccine (PCV-13) and tetanus toxoid vaccine in patients with moderate-to-severe psoriasis during tofacitinib ...
  Kevin L. Winthrop, Neil J. Korman, William Abramovits, Scott T. Rottinghaus, Huaming Tan, Annie Gardner, Geoffrey Mukwaya, Mandeep Kaur, Hernan Valdez> ;Journal of the American Academy of Dermatology. 2018 Jun 1
• 53 citations
  Herpes zoster in psoriasis patients treated with tofacitinib
  Kevin L. Winthrop, Mark Lebwohl, Arnon D. Cohen, Jeffrey M Weinberg, Stephen K. Tyring, Scott T. Rottinghaus, Pankaj Gupta, Kaori Ito, Huaming Tan, Mandeep Kaur, Alexa...> ;Journal of the American Academy of Dermatology. 2017 Aug 1
• 21 citations
  Effect of tofacitinib withdrawal and re-treatment on patient-reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis
  Christopher E.M. Griffiths, Ronald Vender, Howard Sofen, L. Kircik, Huaming Tan, Scott T. Rottinghaus, M. Bachinsky, Lotus Mallbris, Carla Mamolo> ;Journal of the European Academy of Dermatology and Venereology. 2017 Feb 1
• 103 citations
  Tofacitinib attenuates pathologic immune pathways in patients with psoriasis: A randomized phase 2 study
  James G. Krueger, James D. Clark, Mayte Suárez-Fariñas, Judilyn Fuentes-Duculan, Inna Cueto, Claire Q.F. Wang, Huaming Tan, Robert Wolk, Scott T. Rottinghaus, Maryann ...> ;The Journal of Allergy and Clinical Immunology. 2016 Apr 1
• 15 citations
  Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials.
  Matteo Bassetti, Paul C. McGovern, Christoph Wenisch, R. Daniel Meyer, Jean Li Yan, Michele Wible, Scott T. Rottinghaus, Alvaro Quintana> ;International Journal of Antimicrobial Agents. 2015 Sep 1
• 113 citations
  Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial.
  Robert Bissonnette, Lars Iversen, Howard Sofen, Christopher E.M. Griffiths, Peter Foley, Ricardo Romiti, M. Bachinsky, Scott T. Rottinghaus, Huaming Tan, J. Proulx, He...> ;The British Journal of Dermatology. 2015 May 1
• 255 citations
  Combination antifungal therapy for invasive aspergillosis a randomized trial
  Kieren A. Marr, Haran T. Schlamm, Raoul Herbrecht, Scott T. Rottinghaus, Eric J. Bow, Oliver A. Cornely, Werner J. Heinz, Shyla Jagannatha, Liang Piu Koh, Dimitrios P....> ;Annals of Internal Medicine. 2015 Jan 20
• The First Antibody Responses to DNA Vaccines in Humans
  Scott T. Rottinghaus, Gregory A. Poland> ;The Journal of Infectious Diseases. 2008 Jun 1
• 5 citations
  HIV-189.6 Gag expressed from a replication competent HSV-1 vector elicits persistent cellular immune responses in mice
  Scott D. Parker, Scott T. Rottinghaus, Allan J. Zajac, Ling Yue, Eric Hunter, Richard J. Whitley, Jacqueline N. Parker> ;Vaccine. 2007 Sep 17
• 5 citations
  Current non-AIDS antiviral chemotherapy
  Scott T. Rottinghaus, Richard J. Whitley> ;Expert Review of Anti-Infective Therapy. 2007 Apr 1
• 100 citations
  Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination.
  Scott T. Rottinghaus, Gregory A. Poland, Robert M. Jacobson, Lori J. Barr, Mike J Roy> ;Vaccine. 2003 Nov 7
• 36 citations
  Influenza vaccines: a review and rationale for use in developed and underdeveloped countries.
  Gregory A. Poland, Scott T. Rottinghaus, Robert M. Jacobson> ;Vaccine. 2001 Mar 21
• 139 citations
  The C Terminus of Ku80 Activates the DNA-Dependent Protein Kinase Catalytic Subunit
  B. K. Singleton, Maria I. Torres-Arzayus, S. T. Rottinghaus, Guillermo E. Taccioli, Penny A. Jeggo> ;Molecular and Cellular Biology. 1999 May 1
• 77 citations
  The association of ATR protein with mouse meiotic chromosome cores.
  Peter B. Moens, Magdalena Tarsounas, Takashi Morita, Toshiyuki Habu, Scott T. Rottinghaus, Raimundo Freire, Stephen P. Jackson, Carrolee Barlow, Anthony Wynshaw-Boris> ;Chromosoma. 1999 May 1
• 208 citations
  Atm deficiency results in severe meiotic disruption as early as leptonema of prophase I
  Carrolee Barlow, Marek Liyanage, Peter B. Moens, Madalina Tarsounas, Kunio Nagashima, Kevin M. Brown, Scott T. Rottinghaus, Stephen P. Jackson, Danilo A. Tagle, Thomas...> ;Development. 1998 Oct 15
• 130 citations
  Analysis of the ATM protein in wild-type and ataxia telangiectasia cells.
  N. D. Lakin, Peter Weber, Tatjana Stankovic, Scott T. Rottinghaus, Alex M. Taylor, Stephen P. Jackson> ;Oncogene. 1996 Dec 19
• 24 citations
  Expression and purification of recombinant polyomavirus VP2 protein and its interactions with polyomavirus proteins.
  Xiaoyin Cai, Deching Chang, S. Rottinghaus, Richard A. Consigli> ;Journal of Virology. 1994 Nov 1
• Polyomavirus major capsid protein VP1 is capable of packaging cellular DNA when expressed in the baculovirus system.
  Gillock, E. T., Rottinghaus, S., Chang, D., Cai, X., Smiley, S. A., An, K., Consigli, R. A.> ;J Virol. 1997 Apr
• Join now to see all